Dean Felsher
M-TRAM Program Director · Stanford Health Care
Credentials: · · ·
History
PresentM-TRAM · Stanford Health Care
- Present
- Present
Hematology and Medical Oncology
Internal Medicine
Research
MYC regulates the antitumor immune response through CD47 and PD-L1
Science · 2016 · Last of 11 authors · Corresponding · 1,180 citations
The MYC oncogene - the grand orchestrator of cancer growth and immune evasion
Review · Nature Reviews Clinical Oncology · 2022 · Last of 6 authors · Corresponding · 848 citations
MYC as a regulator of ribosome biogenesis and protein synthesis
Review · Nature reviews. Cancer · 2010 · Last of 3 authors · 798 citations
21 papers
13 papers · 2 as a resident
13 papers
9 papers · 4 as a resident
8 papers
7 papers
Jonathan Braun
5 papers
5 papers · 3 as a resident
Grants
- 2024–2031
Stanford Center for Clinical and Translational Research and Education
National Center for Advancing Translational Sciences · UM1
PI · $30.1M · Stanford University
- 2020–2027
Targeting the MYC Pathway for the Treatment of Cancer
National Cancer Institute · R35
Contact PI · $6.9M · Stanford University
- 2023–2027
Molecular Mechanisms by Which Statins Prevent and Reverse Hepatocellular Carcinoma
National Cancer Institute · U01
Contact PI · $1.3M · Stanford University
- 2017–2022
(PQ7)Multi-Scale Analysis of Tumor Microenvironment Heterogeneity
National Cancer Institute · R01
Contact PI · $2.2M · Stanford University
Clinical trials
- 2005–2012
Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
Principal investigator · Completed · Phase 2
Dean Felsher